Literature DB >> 18483624

Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x.

Nuno T Marcos1, Ana Magalhães, Bibiana Ferreira, Maria J Oliveira, Ana S Carvalho, Nuno Mendes, Tim Gilmartin, Steven R Head, Céu Figueiredo, Leonor David, Filipe Santos-Silva, Celso A Reis.   

Abstract

Chronic Helicobacter pylori infection is recognized as a cause of gastric cancer. H. pylori adhesion to gastric cells is mediated by bacterial adhesins such as sialic acid-binding adhesin (SabA), which binds the carbohydrate structure sialyl-Lewis x. Sialyl-Lewis x expression in the gastric epithelium is induced during persistent H. pylori infection, suggesting that H. pylori modulates host cell glycosylation patterns for enhanced adhesion. Here, we evaluate changes in the glycosylation-related gene expression profile of a human gastric carcinoma cell line following H. pylori infection. We observed that H. pylori significantly altered expression of 168 of the 1,031 human genes tested by microarray, and the extent of these alterations was associated with the pathogenicity of the H. pylori strain. A highly pathogenic strain altered expression of several genes involved in glycan biosynthesis, in particular that encoding beta3 GlcNAc T5 (beta3GnT5), a GlcNAc transferase essential for the biosynthesis of Lewis antigens. beta3GnT5 induction was specific to infection with highly pathogenic strains of H. pylori carrying a cluster of genes known as the cag pathogenicity island, and was dependent on CagA and CagE. Further, beta3GnT5 overexpression in human gastric carcinoma cell lines led to increased sialyl-Lewis x expression and H. pylori adhesion. This study identifies what we believe to be a novel mechanism by which H. pylori modulates the biosynthesis of the SabA ligand in gastric cells, thereby strengthening the epithelial attachment necessary to achieve successful colonization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483624      PMCID: PMC2381748          DOI: 10.1172/JCI34324

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Traces of human migrations in Helicobacter pylori populations.

Authors:  Daniel Falush; Thierry Wirth; Bodo Linz; Jonathan K Pritchard; Matthew Stephens; Mark Kidd; Martin J Blaser; David Y Graham; Sylvie Vacher; Guillermo I Perez-Perez; Yoshio Yamaoka; Francis Mégraud; Kristina Otto; Ulrike Reichard; Elena Katzowitsch; Xiaoyan Wang; Mark Achtman; Sebastian Suerbaum
Journal:  Science       Date:  2003-03-07       Impact factor: 47.728

Review 2.  Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation.

Authors:  J C Paulson; K J Colley
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

3.  Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed beta 1----3N-acetylglucosaminyltransferase.

Authors:  E H Holmes; S Hakomori; G K Ostrander
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

4.  Oncofetal expression of Lex carbohydrate antigens in human colonic adenocarcinomas. Regulation through type 2 core chain synthesis rather than fucosylation.

Authors:  E H Holmes; G K Ostrander; H Clausen; N Graem
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

5.  Development of gastric adenocarcinoma in Mongolian gerbils after long-term infection with Helicobacter pylori.

Authors:  Qing Zheng; Xiao Yu Chen; Yao Shi; Shu Dong Xiao
Journal:  J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 4.029

6.  Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.

Authors:  Nuno T Marcos; Sandra Pinho; Catarina Grandela; Andrea Cruz; Bénédicte Samyn-Petit; Anne Harduin-Lepers; Raquel Almeida; Filipe Silva; Vanessa Morais; Julia Costa; Jan Kihlberg; Henrik Clausen; Celso A Reis
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

Review 7.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.

Authors:  P Correa
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

8.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity.

Authors:  Andrew T Gewirtz; Yimin Yu; Uma S Krishna; Dawn A Israel; Sean L Lyons; Richard M Peek
Journal:  J Infect Dis       Date:  2004-04-27       Impact factor: 5.226

10.  Novikoff ascites tumor cells contain N-acetyllactosaminide beta 1 leads to 3 and beta 1 leads to 6 N-acetylglucosaminyltransferase activity.

Authors:  D H van den Eijnden; H Winterwerp; P Smeeman; W E Schiphorst
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

View more
  46 in total

1.  Life at the margins: modulation of attachment proteins in Helicobacter pylori.

Authors:  Mary E Moore; Thomas Borén; Jay V Solnick
Journal:  Gut Microbes       Date:  2011 Jan-Feb

Review 2.  The hypothesis on function of glycosphingolipids and ABO blood groups revisited.

Authors:  Jerzy Kościelak
Journal:  Neurochem Res       Date:  2012-03-11       Impact factor: 3.996

3.  Helicobacter pylori bab genes during chronic colonization.

Authors:  Mario J Matteo; Rita I Armitano; Mariela Romeo; Andres Wonaga; Martín Olmos; Mariana Catalano
Journal:  Int J Mol Epidemiol Genet       Date:  2011-07-23

4.  Atomic force microscopy measurements reveal multiple bonds between Helicobacter pylori blood group antigen binding adhesin and Lewis b ligand.

Authors:  P Parreira; Q Shi; A Magalhaes; C A Reis; J Bugaytsova; T Borén; D Leckband; M C L Martins
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

5.  Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways.

Authors:  Ana Magalhães; Ricardo Marcos-Pinto; Alison V Nairn; Mitche Dela Rosa; Rui M Ferreira; Susana Junqueira-Neto; Daniela Freitas; Joana Gomes; Patrícia Oliveira; Marta R Santos; Nuno T Marcos; Wen Xiaogang; Céu Figueiredo; Carla Oliveira; Mário Dinis-Ribeiro; Fátima Carneiro; Kelley W Moremen; Leonor David; Celso A Reis
Journal:  Biochim Biophys Acta       Date:  2015-07-02

6.  Complexomics study of two Helicobacter pylori strains of two pathological origins: potential targets for vaccine development and new insight in bacteria metabolism.

Authors:  Cédric Bernarde; Philippe Lehours; Jean-Paul Lasserre; Michel Castroviejo; Marc Bonneu; Francis Mégraud; Armelle Ménard
Journal:  Mol Cell Proteomics       Date:  2010-07-07       Impact factor: 5.911

7.  Role for alpha-L-fucosidase in the control of Helicobacter pylori-infected gastric cancer cells.

Authors:  Ta-Wei Liu; Ching-Wen Ho; Hsin-Hung Huang; Sue-Ming Chang; Shide D Popat; Yi-Ting Wang; Ming-Shiang Wu; Yu-Ju Chen; Chun-Hung Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-07       Impact factor: 11.205

Review 8.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

Review 9.  Glycosylation in cancer: mechanisms and clinical implications.

Authors:  Salomé S Pinho; Celso A Reis
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

10.  Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa.

Authors:  Ana Magalhães; Joana Gomes; Mohd Nazri Ismail; Stuart M Haslam; Nuno Mendes; Hugo Osório; Leonor David; Jacques Le Pendu; Rainer Haas; Anne Dell; Thomas Borén; Celso A Reis
Journal:  Glycobiology       Date:  2009-08-25       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.